Genmab — Februar 2024

[JørgenVarnæs]

So far we've seen nothing from the Biontech collab but vailed hints about synergistic effect. I can't point to a single thing in the pipeline with the potential to break through

[Raun]

Tak for din vurdering @Solsen

[E_L]

well we are waiting for GEN1042 /46 data, these are overdue, like HexaCD38 seem all a bit delayed. Not sure if that is due to covid

[JørgenVarnæs]

but perhaps worse - there is a profound lack of phase 3 programs in the pipeline

[E_L]

i their defence, the epco approval was record speed

[E_L]

you need ph1 and 2 first JV, you can't skip a stage unfortunately...

[E_L]

and to start a Ph3 you really need to think you have a winner, i know everyone thinks they have too much money, but they are very costly...

[E_L]

look at how long it takes for Lundbeck's Lu AF82422
of Novo's mim8...

[E_L]

let alone HuMax-IL8
or MAGIC-8
by BMS, when is the lat time we heard anything from them, i think they almost have 10 trials in clinic with that ab

[JørgenVarnæs]

again, indeed you need early stage clinical trials for that - but this is a company going on it's 24rd year, promising breakthrough R&D. And we are still only talking about 1st generation mabs.

[E_L]

but you have to be fair in that only the last few years they have been able to spend real money based on Dara earnings...

[E_L]

and they have been able to hire the staff to do that

[E_L]

we both remember the time they had to fire staff, long time ago...

[E_L]

don't get me wrong, i am also impatient and would love to see more, but i do still like their track record, albeit some with the help of JNJ

[ProinvestorNEWS]

Novo lægger mere end en Genmab til markedsværdien efter opkøb https://www.proinvestor.com/investornyt/1112779/novo-laegger-mere-end-en-genmab-til-markedsvaerdien-efter-opkob

[E_L]

i also would like to see something done with their newer
tech, like hexelect

[JørgenVarnæs]

As I recall, GEN had a stock emission first time the stock hit 1000 and diluted investors by 10%. That was almost 10 years ago and the rationale was to bolster the coffers and secure funds for investments. We've heard that song ever since, but investments have been precious few

[JørgenVarnæs]

Something does not add up

[JørgenVarnæs]

speaking of track record - GEN has a compounded RoI of 9% since IPO

[E_L]

yes, that looks rather shitty today... hence the bad mood here sometimes ... and the mood drives the price again
, it is a nasty circle...